As our product line continues to become more diversified, we have become less dependent on Prozac performance. Major products introduced in the last five years accounted for fully one-third of our sales in 1999 and had a combined growth rate of 41 percent during the year. |
As we expected, the second half of 2005 is bringing stronger sales and earnings growth, |
As we see the cost-containment methods being used by the private sector being now applied now to this Medicare business, I think those plans will extract higher and higher discounts from the industry, |
By taking advantage of this opportunity, Lilly will be able to enhance its focus on pharmaceutical innovation, ... We found Rite Aid's offer attractive because of its value to Lilly and the many synergistic opportunities PCS will have when combined with Rite Aid. |
By taking advantage of this opportunity, Lilly will be able to enhance its focus on pharmaceutical innovation. We found Rite Aid's offer attractive because of its value to Lilly and the many synergistic opportunities PCS will have when combined with Rite Aid. |
Charlie's leadership was pivotal in our drive to increase productivity in every part of Lilly. His ability to transform our organization and raise the bar in every area of performance has been invaluable. His dedication to leadership development is also evident. He leaves behind a strong bench of valued leaders who add value throughout the company. |
During his tenure, Charlie used his broad business experiences and sound judgment to help steer the company through many challenges over the past decade. Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations, transparency in our financial reporting, and strong internal controls. |
Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of $3.10 to $3.20, which represents 8% to 12% growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies. |
He is very well-prepared for the vital role he will play, and I look forward to having him join our senior leadership team. |
I am committing all the necessary resources of the company to address these issues, ... We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible. |
I am committing all the necessary resources of the company to address these issues. We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible. |
I hope they won't push too much farther. If they stopped right now, it'd be fine with me. |
I think there is an overall unreasonable expectation right now that there is such a thing as a risk-free drug. |
In a year of urgent needs, Lilly and its employees stepped forward with extraordinary efforts. To ease the suffering of hurricane and earthquake victims, we gave essential medicines, cash, and supplies. To ensure that seniors and low-income patients had affordable access to drugs, we offered six patient assistance programs. And to halt the spread of multi-drug-resistant tuberculosis, we partnered with the World Health Organizations and other groups to share expertise, improve treatment, and save lives. |
In the short term, I think this will increase access to some people who are not poor enough to be on Medicaid, |